Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Oncolytic Virus Therapies Market by Virus Type (Genetically Engineered Oncolytic Viruses, Oncolytic Wild-Type Viruses), Application (Solid Tumors, Melanoma), End Use (Hospitals, Specialty Clinics, Cancer Research Institute), and Region 2023-2028

Market Overview:

The global oncolytic virus therapies market size reached US$ 130.4 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 492.6 Million by 2028, exhibiting a growth rate (CAGR) of 20.90% during 2023-2028.

Oncolytic virus therapies are a form of immunotherapy that utilizes viruses to infect and destroy cancer cells. They use various natural and genetically modified viruses, such as herpes simplex, Newcastle disease, vaccinia, adenovirus, reovirus, and picornavirus. Oncolytic virus therapies activate danger signals for generating an immune response and are widely used for treating solid tumors, melanoma, and unresectable lesions. They also help eradicate tumors using viruses that only infect and destroy targeted tumor cells. As compared to chemotherapy, oncolytic virus therapies are non-toxic, provide superior efficacy, and prolong the survival of cancer patients. As a result, they find extensive applications in hospitals, clinics, and cancer research institutes.

Oncolytic Virus Therapies Market Trends:

The rising incidences of cancer across the globe are creating a positive outlook for the market. Oncolytic virus therapies are widely used to treat various cancers, such as glioblastoma, breast, lung, and prostate cancers, due to their powerful anti-tumor properties and ability to target tumors accurately without harming surrounding tissues. In line with this, the widespread utilization of the therapy to treat various types of melanomas, such as hematological malignancies, lymphoma, leukemia, and myeloma, is favoring the market growth. Furthermore, rising concerns among patients regarding the negative health impact of various cancer treatments, such as surgical intervention, radiotherapy, chemotherapy, and immunotherapy, are providing a considerable boost to the market growth. Additionally, the rising number of clinical studies in oncolytic viruses, such as herpesvirus, adenovirus, and vaccinia virus, that is in the final stages and have demonstrated excellent experimental results are facilitating the market growth. Other factors, including rising demand for advanced treatments and novel therapies and increasing initiatives by several governments to spread awareness regarding different causes of cancer and promote early diagnosis, are anticipated to drive the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global oncolytic virus therapies market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on virus type, application and end use.

Breakup by Virus Type:

  • Genetically Engineered Oncolytic Viruses
    • Herpes Simplex Virus
    • Adenovirus
    • Vaccinia Virus
  • Oncolytic Wild-Type Viruses
    • Reovirus
    • Newcastle Disease Virus
    • Vesicular Stomatitis Virus
       

Breakup by Application:

  • Solid Tumors
    • Breast Cancer
    • Prostate Cancer
    • Lung Cancer
    • Glioblastoma
  • Melanoma
    • Hematological Malignancies
    • Lymphoma
    • Leukemia
    • Myeloma
       

Breakup by End Use:

  • Hospitals
  • Specialty Clinics
  • Cancer Research Institute
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Amgen Inc., Dnatrix Inc., Genelux Corporation, Lokon Pharma AB, Replimune Group Inc., Rigvir Ltd., Sorrento Therapeutics, Takara Bio Inc. (Takara Holdings Inc.), Targovax, TILT Biotherapeutics Ltd, Transgene SA and Vyriad. Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.

Report Coverage:

Report Features Details
Base Year of the Analysis 2022
    Historical Period 2017-2022
Forecast Period 2023-2028
Units US$ Million
Segment Coverage Virus Type, Application, End Use, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Amgen Inc., Dnatrix Inc., Genelux Corporation, Lokon Pharma AB, Replimune Group Inc., Rigvir Ltd., Sorrento Therapeutics, Takara Bio Inc. (Takara Holdings Inc.), Targovax, TILT Biotherapeutics Ltd, Transgene SA and Vyriad.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Key Questions Answered in This Report:

  • How has the global oncolytic virus therapies market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global oncolytic virus therapies market?
  • What are the key regional markets?
  • What is the breakup of the market based on the virus type?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end use?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global oncolytic virus therapies market and who are the key players?
  • What is the degree of competition in the industry?
     

Key Benefits for Stakeholders:

  • IMARC’s report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the oncolytic virus therapies market from 2017-2028.
  • The research study provides the latest information on the market drivers, challenges, and opportunities in the global oncolytic virus therapies market.
  • The study maps the leading as well as the fastest growing regional markets. It further enables stakeholders to identify the key country-level markets within each region.
  • Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the oncolytic virus therapies industry and its attractiveness.
  • Competitive landscape allows stakeholders to understand their competitive environment and  provides an insight into the current positions of key players in the market.

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Oncolytic Virus Therapies Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Virus Type
    6.1    Genetically Engineered Oncolytic Viruses
        6.1.1 Market Trends
        6.1.2 Key Segments
           6.1.2.1 Herpes Simplex Virus
           6.1.2.2 Adenovirus
           6.1.2.3 Vaccinia Virus
        6.1.3 Market Forecast
    6.2    Oncolytic Wild-Type Viruses
        6.2.1 Market Trends
        6.2.2 Key Segments
           6.2.2.1 Reovirus
           6.2.2.2 Newcastle Disease Virus
           6.2.2.3 Vesicular Stomatitis Virus
        6.2.3 Market Forecast
7    Market Breakup by Application
    7.1    Solid Tumors
        7.1.1 Market Trends
        7.1.2 Key Segments
           7.1.2.1 Breast Cancer
           7.1.2.2 Prostate Cancer
           7.1.2.3 Lung Cancer
           7.1.2.4 Glioblastoma
        7.1.3 Market Forecast
    7.2    Melanoma
        7.2.1 Market Trends
        7.2.2 Key Segments
           7.2.2.1 Hematological Malignancies
           7.2.2.2 Lymphoma
           7.2.2.3 Leukemia
           7.2.2.4 Myeloma
        7.2.3 Market Forecast
8    Market Breakup by End Use
    8.1    Hospitals
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Specialty Clinics
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Cancer Research Institute
        8.3.1 Market Trends
        8.3.2 Market Forecast
9    Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia-Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10    SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11    Value Chain Analysis
12    Porters Five Forces Analysis

    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13    Price Analysis
14    Competitive Landscape

    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    Amgen Inc. 
           14.3.1.1 Company Overview
           14.3.1.2 Product Portfolio
           14.3.1.3 Financials
           14.3.1.4 SWOT Analysis
        14.3.2    Dnatrix Inc.
           14.3.2.1 Company Overview
           14.3.2.2 Product Portfolio
        14.3.3    Genelux Corporation
           14.3.3.1 Company Overview
           14.3.3.2 Product Portfolio
        14.3.4    Lokon Pharma AB
           14.3.4.1 Company Overview
           14.3.4.2 Product Portfolio
        14.3.5    Replimune Group Inc.
           14.3.5.1 Company Overview
           14.3.5.2 Product Portfolio
        14.3.6    Rigvir Ltd.
           14.3.6.1 Company Overview
           14.3.6.2 Product Portfolio
        14.3.7    Sorrento Therapeutics
           14.3.7.1 Company Overview
           14.3.7.2 Product Portfolio
           14.3.7.3 Financials
        14.3.8    Takara Bio Inc. (Takara Holdings Inc.)
           14.3.8.1 Company Overview
           14.3.8.2 Product Portfolio
           14.3.8.3 Financials
        14.3.9    Targovax
           14.3.9.1 Company Overview
           14.3.9.2 Product Portfolio
        14.3.10    TILT Biotherapeutics Ltd
           14.3.10.1 Company Overview
           14.3.10.2 Product Portfolio
        14.3.11    Transgene SA
           14.3.11.1 Company Overview
           14.3.11.2 Product Portfolio
           14.3.11.3 Financials
        14.3.12    Vyriad
           14.3.12.1 Company Overview
           14.3.12.2 Product Portfolio
Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report

List of Figures

Figure 1: Global: Oncolytic Virus Therapies Market: Major Drivers and Challenges
Figure 2: Global: Oncolytic Virus Therapies Market: Sales Value (in Million US$), 2017-2022
Figure 3: Global: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 4: Global: Oncolytic Virus Therapies Market: Breakup by Virus Type (in %), 2022
Figure 5: Global: Oncolytic Virus Therapies Market: Breakup by Application (in %), 2022
Figure 6: Global: Oncolytic Virus Therapies Market: Breakup by End Use (in %), 2022
Figure 7: Global: Oncolytic Virus Therapies Market: Breakup by Region (in %), 2022
Figure 8: Global: Oncolytic Virus Therapies (Genetically Engineered Oncolytic Viruses) Market: Sales Value (in Million US$), 2017 & 2022
Figure 9: Global: Oncolytic Virus Therapies (Genetically Engineered Oncolytic Viruses) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 10: Global: Oncolytic Virus Therapies (Oncolytic Wild-Type Viruses) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Oncolytic Virus Therapies (Oncolytic Wild-Type Viruses) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Oncolytic Virus Therapies (Solid Tumors) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Oncolytic Virus Therapies (Solid Tumors) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Oncolytic Virus Therapies (Melanoma) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Oncolytic Virus Therapies (Melanoma) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Oncolytic Virus Therapies (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Oncolytic Virus Therapies (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Oncolytic Virus Therapies (Specialty Clinics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Oncolytic Virus Therapies (Specialty Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Oncolytic Virus Therapies (Cancer Research Institute) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Oncolytic Virus Therapies (Cancer Research Institute) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: North America: Oncolytic Virus Therapies Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: North America: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: United States: Oncolytic Virus Therapies Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: United States: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Canada: Oncolytic Virus Therapies Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Canada: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: Asia-Pacific: Oncolytic Virus Therapies Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: Asia-Pacific: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: China: Oncolytic Virus Therapies Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: China: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: Japan: Oncolytic Virus Therapies Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: Japan: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: India: Oncolytic Virus Therapies Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: India: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: South Korea: Oncolytic Virus Therapies Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: South Korea: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: Australia: Oncolytic Virus Therapies Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: Australia: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: Indonesia: Oncolytic Virus Therapies Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: Indonesia: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: Others: Oncolytic Virus Therapies Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: Others: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: Europe: Oncolytic Virus Therapies Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: Europe: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: Germany: Oncolytic Virus Therapies Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: Germany: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: France: Oncolytic Virus Therapies Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: France: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: United Kingdom: Oncolytic Virus Therapies Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: United Kingdom: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: Italy: Oncolytic Virus Therapies Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: Italy: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: Spain: Oncolytic Virus Therapies Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: Spain: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: Russia: Oncolytic Virus Therapies Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: Russia: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: Others: Oncolytic Virus Therapies Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: Others: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: Latin America: Oncolytic Virus Therapies Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: Latin America: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Brazil: Oncolytic Virus Therapies Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Brazil: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: Mexico: Oncolytic Virus Therapies Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: Mexico: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: Others: Oncolytic Virus Therapies Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: Others: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: Middle East and Africa: Oncolytic Virus Therapies Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: Middle East and Africa: Oncolytic Virus Therapies Market: Breakup by Country (in %), 2022
Figure 70: Middle East and Africa: Oncolytic Virus Therapies Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: Global: Oncolytic Virus Therapies Industry: SWOT Analysis
Figure 72: Global: Oncolytic Virus Therapies Industry: Value Chain Analysis
Figure 73: Global: Oncolytic Virus Therapies Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Oncolytic Virus Therapies Market: Key Industry Highlights, 2022 & 2028
Table 2: Global: Oncolytic Virus Therapies Market Forecast: Breakup by Virus Type (in Million US$), 2023-2028
Table 3: Global: Oncolytic Virus Therapies Market Forecast: Breakup by Application (in Million US$), 2023-2028
Table 4: Global: Oncolytic Virus Therapies Market Forecast: Breakup by End Use (in Million US$), 2023-2028
Table 5: Global: Oncolytic Virus Therapies Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 6: Global: Oncolytic Virus Therapies Market: Competitive Structure
Table 7: Global: Oncolytic Virus Therapies Market: Key Players


Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links

4